Characteristics for patients receiving a digital rectal examination, stratified by quality metric timing
Patient characteristics | ≤6 months before Tx n=3742 | 6+ months before Tx n=1479 | P value |
Age at diagnosis (years), ![]() ![]() | 65.81±8.83 | 67.54±9.41 | |
Insurance payor type, n (%) | |||
Private | 1219 (77.3) | 357 (22.7) | <0.001 |
Medicare/Medical | 2269 (69.5) | 995 (30.5) | |
Ethnicity, n (%) | |||
Non-Hispanic | 3431 (71.7) | 1353 (28.3) | 0.767 |
Hispanic | 281 (72.4) | 107 (27.6) | |
Race, n (%) | |||
Asian | 423 (73.7) | 151 (26.3) | 0.523 |
White | 2809 (71.4) | 1124 (28.6) | |
Other* | 222 (72.1) | 86 (27.9) | |
First line of treatment, n (%) | |||
Active surveillance | 248 (44.8) | 306 (55.2) | <0.001 |
Chemotherapy | 137 (64.9) | 74 (35.1) | |
Hormone therapy | 768 (62.8) | 455 (37.2) | |
Radiation therapy | 612 (73.6) | 220 (26.4) | |
Surgery | 1977 (82.3) | 424 (17.7) | |
Stage, n (%) | |||
1 | 332 (62.5) | 199 (37.5) | <0.001 |
2 | 2102 (74.5) | 720 (25.5) | |
3 | 607 (84.7) | 110 (15.3) | |
4 | 286 (67.6) | 137 (32.4) |
Tx, treatment.